JP2016188260A5 - - Google Patents

Download PDF

Info

Publication number
JP2016188260A5
JP2016188260A5 JP2016157544A JP2016157544A JP2016188260A5 JP 2016188260 A5 JP2016188260 A5 JP 2016188260A5 JP 2016157544 A JP2016157544 A JP 2016157544A JP 2016157544 A JP2016157544 A JP 2016157544A JP 2016188260 A5 JP2016188260 A5 JP 2016188260A5
Authority
JP
Japan
Prior art keywords
baicalin
bladder
formulation
weight
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016157544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016188260A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016157544A priority Critical patent/JP2016188260A/ja
Priority claimed from JP2016157544A external-priority patent/JP2016188260A/ja
Publication of JP2016188260A publication Critical patent/JP2016188260A/ja
Publication of JP2016188260A5 publication Critical patent/JP2016188260A5/ja
Pending legal-status Critical Current

Links

JP2016157544A 2016-08-10 2016-08-10 五淋散エキス配合製剤 Pending JP2016188260A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016157544A JP2016188260A (ja) 2016-08-10 2016-08-10 五淋散エキス配合製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016157544A JP2016188260A (ja) 2016-08-10 2016-08-10 五淋散エキス配合製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014219090A Division JP6230519B2 (ja) 2014-10-28 2014-10-28 五淋散エキス配合製剤

Publications (2)

Publication Number Publication Date
JP2016188260A JP2016188260A (ja) 2016-11-04
JP2016188260A5 true JP2016188260A5 (enrdf_load_stackoverflow) 2017-02-16

Family

ID=57239503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016157544A Pending JP2016188260A (ja) 2016-08-10 2016-08-10 五淋散エキス配合製剤

Country Status (1)

Country Link
JP (1) JP2016188260A (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108324810A (zh) * 2017-01-20 2018-07-27 苏海刚 一种治疗前列腺炎的中药制剂

Similar Documents

Publication Publication Date Title
PH12013500081B1 (en) Aqueous composition comprising bromhexine
JP2014129360A5 (enrdf_load_stackoverflow)
JP2014507482A5 (enrdf_load_stackoverflow)
HRP20200434T1 (hr) Stabilne vodene formulacije adalimumaba
JP2014218522A5 (enrdf_load_stackoverflow)
HRP20230809T1 (hr) Liječenje alzheimerove bolesti u određenoj populaciji bolesnika
JP2016135110A5 (enrdf_load_stackoverflow)
EP4410833A3 (en) Compositions and methods for treating fatty tissue buildup
JP2016014009A5 (enrdf_load_stackoverflow)
JP2015514739A5 (enrdf_load_stackoverflow)
FR2999086B1 (fr) Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation
IL208751A0 (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood
JP2015531396A5 (enrdf_load_stackoverflow)
JP2016188260A5 (enrdf_load_stackoverflow)
MX384303B (es) Composiciones y métodos para metabolismo muscular mejorado.
JP2016535762A5 (enrdf_load_stackoverflow)
JP2018509479A5 (enrdf_load_stackoverflow)
WO2015160249A3 (en) Use of enoximone in the treatment of atopic immune-related disorders, in pharmaceutical composition as well as in pharmaceutical preparation
JP2015113322A5 (enrdf_load_stackoverflow)
HRP20171896T1 (hr) Liječenje i prevencija alzheimerove bolesti
JP2015536999A5 (enrdf_load_stackoverflow)
FR3005407B1 (fr) Kit a usage unique pour la preparation de principes actifs par dissolution et/ou chauffage
ES2444299B1 (es) Uso de un hidrolizado de caseina como agente antiherpético
WO2019088958A3 (en) The use of jerusalem thorn fruits as herbal tea for diabetes treatment
岡本香弥 Impact of eicosapentaenoic acid/arachidonic acid ratio on left ventricular structure in patients with diabetes